Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC
Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
|3||Active, not recruiting||
Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
|4||Active, not recruiting||
Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma
Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma
† Study has passed its completion date and status has not been verified in more than two years.